Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease

American Heart Journal

Volumn 145, Issue 2, 2003, Pages 330-333

  Matsui, Keiji ^a   Ikeda, Uichi ^a   Murakami, Yoshiaki ^a   Yoshioka, Toru ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CILOSTAZOL; ENDOTHELIN 1; INTERLEUKIN 6; MICROSPHERE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E1; TICLOPIDINE; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG FORMULATION; FEMALE; HUMAN; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0037328839     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.145     Document Type: Article

References (20)

1. Mangiafico RA, Messina R, Attina T, et al. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication. Angiology 2000;51:441-9.
2. Mangiafico RA, Malatino LS, Santonocito M, et al. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication. Int J Clin Pharmacol Ther 1999;37;347-51.
3. Gianetti J, De Caterina M, De Cristofaro T, et al. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease. Am Heart J 2001;142:733-9.
4. Mehrabi MR, Ekmekcioglu C, Stanek B, et al. Angiogenesis stimulation in explanted hearts from patients pre-treated with intravenous prostaglandin E(1). Heart Lung Transplant 2001;20:465-73.
5. Conti P, DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 2001;22:133-7.
6. Gerszten GE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718-23.
7. Takeya M, Yoshimura T, Leonard EJ, et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993;24:534-9.
8. Takahashi M, Masuyama J, Ikeda U, et al. Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration I vitro. Arterioscler Thromb Vasc Biol 1995;15:629-36.
9. Seino Y, Ikeda U, Sekiguchi H, et al. Expression of leukocyte chemotactic cytokines in myocardial tissue. Cytokine 1995;7:301-4.
10. Yu X, Dluz S, Graves DT, et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates, Proc Natl Acad Sci U S A 1992;89:6953-7.
11. Aiello RJ, Bourassa PA, Lindsey S, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999;19:1518-25.
12. Reckless J, Rubin EM, Verstuyft JB, et al. Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. Circulation 1999;99:2310-6.
13. Martin CA, Dorf ME. Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 1991;135:245-58.
14. Hojo Y, Ikeda U, Takahashi M, et al. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002;161:403-8.
15. Matsumori A, Furukawa Y, Hashimoto T, et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 ar elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997;29:419-23.
16. Yla-Herttuala S, Lipton BA, Rosenfeld ME, et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991;88:5252-6.
17. Satriano JA, Hora K, Shan Z, et al. Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 1993;150:1971-8.
18. Rolfe MW, Kunkel SL, Standiford TJ, et al. Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. Am J Physiol 1992;263:L536-45.
19. Takahashi M, Masuyama J, Ikeda U, et al. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothetial migration in vitro. Circ Res 1995;76:750-7.
20. Weiss C, Regele S, Velich T, et al. Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandins. Leukoc Essential Fatty Acids 2000;63:271-7.